Insider trades › Elevance Health › Gail Boudreaux
Gail Boudreaux: Elevance Health stock transactions
Gail Boudreaux (President and CEO, Director at Elevance Health) reported 2 transactions in ELV stock on SEC Form 4 over the last 120 days. Name as filed with the SEC: BOUDREAUX GAIL.
$0open-market sales (0 shares)
$1.0Mopen-market purchases (2,725 shares)
2026-07-17most recent transaction
Transactions
| Date | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|
| Jul 17, 2026 | Open-market purchase | 680 | $366.41 | $249K | Form 4 ↗ |
| Jul 17, 2026 | Open-market purchase | 2,045 | $368.25 | $753K | Form 4 ↗ |
Source: SEC EDGAR Form 4 filings; each row links to the filing. Sales marked "10b5-1 plan" were reported as made under a pre-arranged trading plan. Insider trades are reported facts, not recommendations. Not investment advice.